Related Experiment Video

Updated: Aug 19, 2026

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases
07:47

Anti-virulent Disruption of Pathogenic Biofilms using Engineered Quorum-quenching Lactonases

Published on: January 1, 2016

[The efficacy of kurantil and its effect on thrombocytic hemostasis in patients with chronic glomerulonephritis]

M O Kolesnyk, I I Lapchyns'ka, H O Bielyts'ka

    Likars'Ka Sprava
    |September 1, 1994
    PubMed

    Insights

    Curantyl (C) shows therapeutic potential in chronic glomerulonephritis (ChGN), with efficacy predictable by baseline proteinuria and fibrin degradation product levels. Some severe ChGN cases responded positively to Curantyl treatment.

    Area of Science:

    • Nephrology
    • Pharmacology

    Context:

    • Chronic glomerulonephritis (ChGN) presents complex challenges in treatment.
    • Understanding the mechanisms of anti-aggregant and vasoactive drugs is crucial for managing ChGN.

    Purpose:

    • To investigate the anti-aggregant and vasoactive effects of Curantyl (C) in patients with chronic glomerulonephritis (ChGN).
    • To identify predictors of Curantyl treatment efficacy in ChGN patients.

    Summary:

    • This study examined 85 patients with ChGN treated with Curantyl (C).
    • Positive treatment effects were observed in 35.5% of patients, with negative effects in 12.9% and no effect in 25.8%.
    • Notably, prognostically unfavorable forms of ChGN responded to Curantyl therapy in some cases.
    • Treatment efficacy was predictable based on baseline 24-hour proteinuria and the reduction in urinary fibrinogen/fibrin degradation products within the first week.

    Impact:

    • Curantyl demonstrates potential in managing chronic glomerulonephritis, even in severe cases.
    • Predictive markers for Curantyl efficacy can optimize patient selection and treatment strategies.
    • This research contributes to understanding drug mechanisms and improving therapeutic outcomes in nephrology.

    More Related Videos

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

    Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

    Published on: August 23, 2024

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well08:01

    The Nijmegen Hemostasis Assay: Simultaneous Fluorogenic Measurement of Thrombin and Plasmin Generation in a Single Well

    Published on: February 27, 2026

    Related Concept Videos

    Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

    Anticoagulant Drugs: Low-Molecular-Weight Heparins

    Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

    Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

    Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
    Venous Thrombosis III: Interprofessional Care01:29

    Venous Thrombosis III: Interprofessional Care

    Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
    Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

    Acute Kidney Injury IV: Diagnostic Studies and Prevention

    Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...